相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing of Auranofin Against Bacterial Infections: An In silico and In vitro Study
Nidhi Sharma et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp.
Pengfei She et al.
JOURNAL OF APPLIED MICROBIOLOGY (2020)
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019
J. D. Jenks et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Direct Observation of Methylmercury and Auranofin Binding to Selenocysteine in Thioredoxin Reductase
Ingrid J. Pickering et al.
INORGANIC CHEMISTRY (2020)
Mutation in trxB leads to auranofin resistance in Staphylococcus aureus
Haoran Chen et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Advances in understanding and managing Scedosporium respiratory infections in patients with cystic fibrosis
Jean-Philippe Bouchara et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)
Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae
Ahmed Elkashif et al.
SCIENTIFIC REPORTS (2020)
Auranofin Rapidly Eradicates Methicillin-resistant Staphylococcus aureus (MRSA) in an Infected Pressure Ulcer Mouse Model
Haroon Mohammad et al.
SCIENTIFIC REPORTS (2020)
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
Hongzhe Sun et al.
NATURE COMMUNICATIONS (2020)
Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections
Liwen Feng et al.
MOLECULES (2020)
Honokiol Reduces Fungal Load, Toll-Like Receptor-2, and Inflammatory Cytokines in Aspergillus fumigatus Keratitis
Lu Zhan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)
Transcriptional profiling of Scedosporium apiospermum enzymatic antioxidant gene battery unravels the involvement of thioredoxin reductases against chemical and phagocytic cells oxidative stress
Cindy Staerck et al.
MEDICAL MYCOLOGY (2019)
Interactions between anti-infective agents and immunosuppressants-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Tracy Sparkes et al.
CLINICAL TRANSPLANTATION (2019)
Antifungal Effect of Magnolol and Honokiol from Magnolia officinalis on Alternaria alternata Causing Tobacco Brown Spot
Ya-Han Chen et al.
MOLECULES (2019)
A validated ultra-HPLC-MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study
Quankun Zhuang et al.
BIOANALYSIS (2019)
Stress-Activated Protein Kinases in Human Fungal Pathogens
Alison M. Day et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis
Pengfei She et al.
FRONTIERS IN MICROBIOLOGY (2019)
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScopeA®
Danila Seidel et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2019)
Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis
Carsten Schwarz et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum
C. Staerck et al.
MYCOPATHOLOGIA (2018)
Saccharomyces cerevisiae Hog1 MAP kinase pathway is activated in response to honokiol exposure
L. -M. Sun et al.
JOURNAL OF APPLIED MICROBIOLOGY (2018)
Scedosporium and Lomentospora: an updated overview of underrated opportunists
Andoni Ramirez-Garcia et al.
MEDICAL MYCOLOGY (2018)
Safety and Toxicology of Magnolol and Honokiol
Andrea Sarrica et al.
PLANTA MEDICA (2018)
Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
Holly C. May et al.
FRONTIERS IN MICROBIOLOGY (2018)
Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development
Gina Wall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Genome-wide screening of budding yeast with honokiol to associate mitochondrial function with lipid metabolism
Xiaolong Zhu et al.
TRAFFIC (2018)
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi
Nathan P. Wiederhold et al.
VIRULENCE (2017)
Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation
Adela Martin-Vicente et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Transcriptomic analysis of Saccharomyces cerevisiae upon honokiol treatment
Xiaolong Zhu et al.
RESEARCH IN MICROBIOLOGY (2017)
Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience
Perrine Parize et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway
Shankar Thangamani et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction
Lingmei Sun et al.
PLOS ONE (2017)
Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in Candida albicans
Lingmei Sun et al.
PLOS ONE (2017)
Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells
Shankar Thangamani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity
Huy X. Ngo et al.
CHEMMEDCHEM (2016)
Adverse effects of voriconazole: Over a decade of use
Miriam T. Levine et al.
CLINICAL TRANSPLANTATION (2016)
Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin
Beth Burgwyn Fuchs et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp.
Tarcieli Pozzebon Venturini et al.
MEDICAL MYCOLOGY (2016)
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
Shankar Thangamani et al.
SCIENTIFIC REPORTS (2016)
Future trends in cystic fibrosis demography in 34 European countries
Pierre-Regis Burgel et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans
Lingmei Sun et al.
PLOS ONE (2015)
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
Michael B. Harbut et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
Shankar Thangamani et al.
PLOS ONE (2015)
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
Shankar Thangamani et al.
SCIENTIFIC REPORTS (2015)
Treatment of Erythrocytes with the 2-Cys Peroxiredoxin Inhibitor, Conoidin A, Prevents the Growth of Plasmodium falciparum and Enhances Parasite Sensitivity to Chloroquine
Mariana Brizuela et al.
PLOS ONE (2014)
Peroxiredoxin-1 from the Human Hookworm Ancylostoma ceylanicum Forms a Stable Oxidized Decamer and Is Covalently Inhibited by Conoidin A
Jennifer B. Nguyen et al.
CHEMISTRY & BIOLOGY (2013)
Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
Michaela Lackner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients
S. Rondeau et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Fungal antioxidant pathways promote survival against neutrophils during infection
Sixto M. Leal et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Anjan Debnath et al.
NATURE MEDICINE (2012)
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
Ramesh K. Ramanathan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans
J. Jin et al.
LETTERS IN APPLIED MICROBIOLOGY (2010)
Identification of conoidin A as a covalent inhibitor of peroxiredoxin II
Jeralyn D. Haraldsen et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model
Qi-qi Jiang et al.
BMC CANCER (2008)
A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors
Ramesh K. Ramanathan et al.
CLINICAL CANCER RESEARCH (2007)
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex
Felix Gilgado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: Clinical characteristics and impact of antifungal agent therapy on outcome
S Husain et al.
CLINICAL INFECTIOUS DISEASES (2005)
A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii
KL Carey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis
WJ Syu et al.
CHEMISTRY & BIODIVERSITY (2004)
The diversity and evolution of thioredoxin reductase:: new perspectives
RP Hirt et al.
TRENDS IN PARASITOLOGY (2002)
Antifungal activity of magnolol and honokiol
KH Bang et al.
ARCHIVES OF PHARMACAL RESEARCH (2000)
分享论文
